# ALERE INC.

ALERE INC. is a company headquartered in Waltham, MA, United States.

## Company overview

- **Legal name:** ALERE INC.
- **Former names in filing history:** INVERNESS MEDICAL INNOVATIONS INC (2001-10-19 to 2010-07-09)
- **Classification:** Company
- **Industry (SIC):** 2835 — In Vitro & In Vivo Diagnostic Substances
- **Headquarters:** Waltham, MA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001145460

## About

ALERE INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001145460, and its reported industry is In Vitro & In Vivo Diagnostic Substances. In 10-K filed on 2017-06-05, it reported annual revenue of USD 2,376,335,000; net income of USD -137,619,000; total assets of USD 5,648,279,000 for the fiscal period ended 2016-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2016 (period ended 2016-12-31)

- **Revenue:** $2.4B (USD 2,376,335,000)
- **Net income:** -$137.6M (USD -137,619,000)
- **Total assets:** $5.6B (USD 5,648,279,000)
- **Cash and equivalents:** $567.2M (USD 567,215,000)
- **Operating cash flow:** $179.3M (USD 179,290,000)

### FY2015 (period ended 2015-12-31)

- **Revenue:** $2.5B (USD 2,463,316,000)
- **Net income:** $206.4M (USD 206,376,000)
- **Total assets:** $6.0B (USD 5,957,171,000)
- **Cash and equivalents:** $502.2M (USD 502,200,000)
- **Operating cash flow:** $207.3M (USD 207,282,000)
- **Later filings:** Revenue, Net income, Total assets: shown as originally filed; later filings report different values for the same periods.

### FY2014 (period ended 2014-12-31)

- **Revenue:** $2.6B (USD 2,586,690,000)
- **Net income:** $9.9M (USD 9,918,000)
- **Total assets:** $6.7B (USD 6,718,041,000)
- **Cash and equivalents:** $378.5M (USD 378,461,000)
- **Operating cash flow:** $233.8M (USD 233,831,000)
- **Later filings:** Revenue, Net income, Total assets, Operating cash flow: shown as originally filed; later filings report different values for the same periods.

### FY2013 (period ended 2013-12-31)

- **Revenue:** $3.0B (USD 3,029,442,000)
- **Net income:** -$71.3M (USD -71,254,000)
- **Total assets:** $7.1B (USD 7,060,814,000)
- **Cash and equivalents:** $361.9M (USD 361,908,000)
- **Operating cash flow:** $244.8M (USD 244,777,000)
- **Later filings:** Revenue, Net income, Total assets, Cash and equivalents, Operating cash flow: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2017-10-03 — period 2017-10-03 — 8-K
- Form 8-K — filed 2017-09-19 — period 2017-09-15 — FORM 8-K
- Form 10-Q — filed 2017-08-03 — period 2017-06-30 — FORM 10-Q
- Form 8-K — filed 2017-08-03 — period 2017-08-03 — FORM 8-K
- Form 8-K — filed 2017-07-21 — period 2017-07-21 — FORM 8-K
- Form 8-K — filed 2017-07-17 — period 2017-07-15 — FORM 8-K
- Form 8-K — filed 2017-07-10 — period 2017-07-07 — FORM 8-K
- Form 8-K — filed 2017-06-14 — period 2017-06-14 — 8-K
- Form 10-Q — filed 2017-06-14 — period 2017-03-31 — FORM 10-Q
- Form 8-K — filed 2017-06-05 — period 2017-06-05 — FORM 8-K
- Form 10-K — filed 2017-06-05 — period 2016-12-31 — FORM 10-K
- Form 8-K — filed 2017-05-30 — period 2017-05-30

---

Updated: 2026-10-23T20:08:00Z

Canonical page: https://altss.com/profile/alere-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology